Notifications on Data Integrity

FDA notifications for industry on data integrity.

FDA to pharmaceutical companies: Certain studies conducted by Raptim Research Pvt. Ltd. are unacceptable

FDA has identified significant data integrity and study conduct concerns with bioequivalence and bioavailability studies conducted by Raptim Research Pvt.…

Study Data Technical Conformance Guide – Technical Specifications Document

This technical specifications document represents the Food and Drug Administration’s (FDA’s) current thinking on this topic.

Meetings, Conferences, & Workshops | Drugs

Meetings, conferences, and workshops sponsored or co-sponsored by Center for Drug Evaluation and Research.

Implementing FDA’s IVPT Guidance Recommendations: A Step-By-Step Illustration – 04/29/2025

The workshop will clarify the intent of FDA recommendations for IVPT studies, with step-by-step demonstrations illustrating how IVPT study procedures…

CDER Data Standards Program

CDER Data Standards Program

Data Standards Program Strategic Plan and Board

The Data Standards Strategy reinforces CDER’s ongoing commitment to the development, implementation, and maintenance of a comprehensive data standards program…

Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis

Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis. Monitor liver…

Analysis of Testosterone Esters in Serum and DBS Samples—Results From an Interlaboratory Study

An interlaboratory study was conducted to compare the detection capabilities of testosterone esters in blood matrices. Serum-, cellulose- and polymer-based…